Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T. Wong, MD, David Schwartz, MD, Joseph P. Weiner, MD, Virginia W. Osborn, MD, David Schreiber, MD The Annals of Thoracic Surgery Volume 102, Issue 2, Pages 433-438 (August 2016) DOI: 10.1016/j.athoracsur.2016.02.058 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival estimates were derived for patients with pathologic complete response (pCR) and residual disease after esophagectomy. The Annals of Thoracic Surgery 2016 102, 433-438DOI: (10.1016/j.athoracsur.2016.02.058) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions